ROVI’s Alcalá de Henares plant receives the visit of the Romanian Health Minister

The Minister, Alexandru Rafila, was accompanied by the Director of Cabinet of the Romanian Ministry of Health and the Romanian Ambassador to Spain.

Madrid, 6th February, 2023

This Monday, the Romanian Minister of Health, Alexandru Rafila, visited the ROVI plant in Alcalá de Henares. The Chief of Staff of the Romanian Health Ministry, Raluca Puiu, and the Romanian ambassador to Spain, George Gabriel Bologan, were also present. The Romanian authorities were accompanied by ROVI’s Chairman and Chief Executive Officer, Juan López-Belmonte, the Industrial Manager, Miguel Ángel Ortega, and the Manager of the Alcalá de Henares plant, Pilar García-Morato Saro.

The ROVI plant in Alcalá de Henares is one of the Laboratory’s three plants engaged in the CMO (contract manufacturing organisation) business, the purpose of which is to respond to the growing need for pharmaceutical companies to outsource their manufacturing processes. The Alcalá plant specialises in the production of oral solid forms and has become a centre of excellence for the group’s packaging of both solid products and injectables.

ROVI is one of the main sector companies in the high value-added CMO business, with exports to over 50 countries. The majority of its sales are international and it is highly technologically specialised in the area of manufacturing vaccines, biological products and biosimilars, all of which are products with a recognised therapeutic value.

During the visit, the Romanian Health Minister, Alexandru Rafila, observed the plant’s manufacturing processes in detail and met with Juan López-Belmonte, the Chairman and Chief Executive Officer of ROVI.

Average: 1 (2 votes)
​ The company will be submitting for the approval of the Ordinary General Shareholders’ Meeting the annual accounts for the financial...
9 min
​The new facility has meant an investment of 11 million euros This new line, which has now been authorised to commence commercial...
3 min
Operating revenue was 151.2 million euros in the first quarter of 2024, a 25% decrease on the first quarter of 2023, mainly due...
4 min